Gloucester Pharmaceuticals
Gloucester Pharmaceuticals was a Cambridge, Massachusetts biopharmaceutical company focused on cancer therapies. It developed and commercialised ISTODAX for T-cell lymphoma before Celgene acquired the company in 2010.
Key facts
| Company Operating Status | Acquired |
|---|---|
| Wellfound ID | gloucester-pharmaceuticals |